Nov 1, 2022, 10:40 by

Nov 1, 2022, 10:40 by

Nov 1, 2022, 10:40 by

Nov 1, 2022, 01:00 by User Not Found

Clinical Research News | Various stakeholders across the clinical trial enterprise are launching an initiative to reduce the environmental impact of clinical research. Jason LaRoche, Director of Clinical Innovation at Janssen Pharmaceuticals, stands at the helm of this ambitious project, aiming to quantify clinical trial greenhouse gas emissions and drastically reduce the adverse downstream effects of research operations.

Oct 31, 2022, 17:34 by

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

Oct 31, 2022, 17:34 by

Oct 28, 2022, 09:54 by

Oct 28, 2022, 09:43 by

Samsung Biologics a leading contract development and manufacturing organization, released today its fiscal year 2022 third-quarter financial results.

Oct 28, 2022, 09:42 by

Ardigen has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise

Oct 27, 2022, 10:16 by

Oct 27, 2022, 10:15 by

Contact information Eric Blair, Chief Commercial Officer Eric.Blair@AndelynBio.com For media enquiries, please contact Imogen Quail, PR Manager, imogen.quail@ramarketingpr.com, ramarketingpr.com About Andelyn Biosciences, Inc. Andelyn is a biopharmaceutical CDMO Pioneering Solutions That Turn Hope into Reality™. Headquartered in the greater Columbus, Ohio, USA area, Andelyn’s capabilities span viral vector process and analytical development, small to large scale adherent and suspension based GMP drug substance manufacturing up to 2000L, and drug product manufacturing services. Having 20+ years of experience in viral vector manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders that have enabled 75+ worldwide clinical trials. With the experience gained from over 400 cGMP clinical batches and 2000+ research-grade productions, Andelyn provides its clients with end-to-end manufacturing services, advanced quality systems, full regulatory support, and supply chain vertical integration. Andelyn began operations in its state-of-the-art 200,000 sq. ft. commercial manufacturing facility in September 2022, expanding capacity across 14+ production suites for customization of new programs and tech transferred programs. Andelyn is one of a few select CDMOs that offer clinical through commercial-scale capabilities that will help fulfil Andelyn’s mission of accelerating the development and manufacturing of innovative therapies to bring more treatments to more patients. Andelyn is owned and supported by Nationwide Children’s Hospital (NCH) and Pall-Cytiva, part of Danaher Corporation. For more information, visit: https://andelynbio.com/.

Oct 27, 2022, 01:00 by User Not Found

Clinical Research News | A new application that enables real-time data access for sponsors and clinical research sites; a first-of-its-kind solution for aggregating, cleaning, and transforming clinical data; two new applications to help clinical teams improve site selection and optimize trial design; and more.

Oct 26, 2022, 10:13 by

GenNext Technologies, Inc. has announced that it received the 2022 Grand Prize Award in the BioTools Innovator competition.

Oct 26, 2022, 10:13 by

Oncodesign Services and Elyan Partners announce the completion of the acquisition of a majority stake in Oncodesign Services by ERES IV, from its main shareholders.

Oct 26, 2022, 10:12 by

Inizio commits to Science Based Targets initiative

Oct 26, 2022, 10:11 by

Oct 26, 2022, 01:00 by User Not Found

Clinical Research News | Funding for biomedical research through high-performance computing, comparative clinical effectiveness research to reduce inequities in maternal health care and outcomes, identifying vulnerabilities in pediatric cancers, and more.

Oct 24, 2022, 11:21 by

Oct 24, 2022, 11:20 by

Spray drying specialist and capsule filling service contract development and manufacturing organisation (CDMO) Micro-Sphere has invested over €5 million to expand its GMP manufacturing capabilities at its facility in Monteggio, Switzerland.

Oct 24, 2022, 11:20 by

Advanced IRT system enhanced with self-service functionality to quickly address trial challenges